Start-ups & Opportunities
London's Sava raises $36 million to replace fingerstick glucose tests with a microsensor
London medtech start-up Sava raised a $36 million Series B led by Ascensia, announced around October 9, 2026, to bring its glucose microsensor to market.
11 Oct 2026 · 3 min read